Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1996 4
1997 2
1998 2
1999 5
2000 2
2001 2
2002 1
2003 8
2004 3
2005 3
2006 1
2007 6
2008 2
2009 7
2010 8
2011 8
2012 18
2013 18
2014 15
2015 14
2016 5
2017 5
2018 6
2019 10
2020 13
2021 11
2022 3
2023 2
2024 3
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

174 results

Results by year

Filters applied: . Clear all
Page 1
Lung Cancer in Austria.
Pirker R, Prosch H, Popper H, Klepetko W, Dieckmann K, Burghuber OC, Klikovits T, Hoda MA, Zöchbauer-Müller S, Filipits M. Pirker R, et al. Among authors: filipits m. J Thorac Oncol. 2021 May;16(5):725-733. doi: 10.1016/j.jtho.2020.10.158. J Thorac Oncol. 2021. PMID: 33896572 Free article. No abstract available.
Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop.
Pirker R, Herth FJ, Kerr KM, Filipits M, Taron M, Gandara D, Hirsch FR, Grunenwald D, Popper H, Smit E, Dietel M, Marchetti A, Manegold C, Schirmacher P, Thomas M, Rosell R, Cappuzzo F, Stahel R; European EGFR Workshop Group. Pirker R, et al. Among authors: filipits m. J Thorac Oncol. 2010 Oct;5(10):1706-13. doi: 10.1097/JTO.0b013e3181f1c8de. J Thorac Oncol. 2010. PMID: 20871269 Free article.
Cetuximab in non-small-cell lung cancer.
Pirker R, Filipits M. Pirker R, et al. Among authors: filipits m. Transl Lung Cancer Res. 2012 Mar;1(1):54-60. doi: 10.3978/j.issn.2218-6751.11.01. Transl Lung Cancer Res. 2012. PMID: 25806155 Free PMC article. Review.
Federated Deep Learning Enables Cancer Subtyping by Proteomics.
Cai Z, Boys EL, Noor Z, Aref AT, Xavier D, Lucas N, Williams SG, Koh JMS, Poulos RC, Wu Y, Dausmann M, MacKenzie KL, Aguilar-Mahecha A, Armengol C, Barranco MM, Basik M, Bowman ED, Clifton-Bligh R, Connolly EA, Cooper WA, Dalal B, DeFazio A, Filipits M, Flynn PJ, Graham JD, George J, Gill AJ, Gnant M, Habib R, Harris CC, Harvey K, Horvath LG, Jackson C, Kohonen-Corish MRJ, Lim E, Liu JJ, Long GV, Lord RV, Mann GJ, McCaughan GW, Morgan L, Murphy L, Nagabushan S, Nagrial A, Navinés J, Panizza BJ, Samra JS, Scolyer RA, Souglakos J, Swarbrick A, Thomas D, Balleine RL, Hains PG, Robinson PJ, Zhong Q, Reddel RR. Cai Z, et al. Among authors: filipits m. Cancer Discov. 2025 Sep 4;15(9):1803-1818. doi: 10.1158/2159-8290.CD-24-1488. Cancer Discov. 2025. PMID: 40488620 Free PMC article.
BRCA1/2 and Other Predisposition Genes in High-Risk Hormone Receptor+/Human Epidermal Growth Factor Receptor 2- Breast Cancer Treated With Endocrine Therapy With or Without Palbociclib: A Secondary PENELOPE-B Study Analysis.
Hahnen E, Hauke J, Gelmon K, Marmé F, Ernst C, Martin M, Untch M, Bonnefoi H, Knudsen E, Im SA, DeMichele A, Van't Veer L, Kim SB, Bear H, McCarthy N, Rhiem K, Turner N, Witkiewicz A, Rojo F, Filipits M, Martin LA, Fasching PA, Schem C, Becker K, García-Sáenz JA, Kelly CM, Reimer T, Toi M, Rugo HS, Denkert C, Gnant M, Makris A, Liu Y, Valota O, Felder B, Weber K, Nekljudova V, Loibl S. Hahnen E, et al. Among authors: filipits m. JCO Precis Oncol. 2025 Apr;9:e2400742. doi: 10.1200/PO-24-00742. Epub 2025 Apr 10. JCO Precis Oncol. 2025. PMID: 40209141 Free PMC article. Clinical Trial.
The potential of liquid biopsies.
Buder A, Tomuta C, Filipits M. Buder A, et al. Among authors: filipits m. Curr Opin Oncol. 2016 Mar;28(2):130-4. doi: 10.1097/CCO.0000000000000267. Curr Opin Oncol. 2016. PMID: 26730486 Review.
Monocyte subsets in breast cancer patients under treatment with aromatase inhibitor and mucin-1 cancer vaccine.
Knöbl V, Maier L, Grasl S, Kratzer C, Winkler F, Eder V, Hayden H, Sahagun Cortez MA, Sachet M, Oehler R, Frantal S, Fesl C, Zehetner K, Pfeiler G, Bartsch R, Fitzal F, Singer CF, Filipits M, Gnant M, Brostjan C. Knöbl V, et al. Among authors: filipits m. J Transl Med. 2024 Oct 8;22(1):913. doi: 10.1186/s12967-024-05659-w. J Transl Med. 2024. PMID: 39380101 Free PMC article.
Neoadjuvant atezolizumab in combination with dual HER2 blockade plus epirubicin in women with early HER2-positive breast cancer: the randomized phase 2 ABCSG-52/ATHENE trial.
Rinnerthaler G, Egle D, Bartsch R, Schmitt CA, Petzer A, Balic M, Petru E, Denison U, Singer CF, Bjelic-Radisic V, Gampenrieder SP, Knauer M, Sotlar K, Brunner C, Posch F, Hlauschek D, Sölkner L, Bago-Horvath Z, Filipits M, Gili M, Ritter M, Wieser V, Albertini C, Zaborsky N, Weiss L, Marhold M, Schneeweiss B, Pusch R, Gnant M, Greil R. Rinnerthaler G, et al. Among authors: filipits m. Nat Cancer. 2025 Jan;6(1):41-50. doi: 10.1038/s43018-024-00890-2. Epub 2025 Jan 16. Nat Cancer. 2025. PMID: 39820125 Free PMC article. Clinical Trial.
Pertuzumab in breast cancer: a systematic review.
Zagouri F, Sergentanis TN, Chrysikos D, Zografos CG, Filipits M, Bartsch R, Dimopoulos MA, Psaltopoulou T. Zagouri F, et al. Among authors: filipits m. Clin Breast Cancer. 2013 Oct;13(5):315-24. doi: 10.1016/j.clbc.2013.05.002. Epub 2013 Jun 27. Clin Breast Cancer. 2013. PMID: 23810292
174 results